Therapeutic efficacy of intense pulsed light for treatment of meibomian gland dysfunction in glaucoma patients

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 70 人开始时间: 2020年7月9日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Glaucoma patients treated with 1 or more eye drops that have MGD with more than or equal to 2 items as follows
•1. redness or thickening lid margin
•2. Telangiectasia
•3. reduced secretions of meibum or poor quality secretion of meibum
•4. Meibomian gland loss
•5. abnormal tear break-up time (TBUT)

•1. there are other diseases of the eyelids and cornea.
•2. have a congenital disease affecting the eyes.
•3. having a history of corneal transplantation or glaucoma surgery.
•4. have been punctual occlusion to treat dry eye before.
•5. use eye drops that regularly affect the cornea, including antibiotics and anti-inflammatory drugs.
•6. use the following drugs regularly: hormones that treat menopause symptoms (Estrogen, Progestin), Antihistamine, Anti-anxiety disorder and Tricyclic antidepressant, Retinoids
•7. light allergies, facial herpes and epilepsy.
•8. unable to cooperate with the examination with a slit lamp biomicroscopy and using an IPL
•9. people with severe side effects from IPL lasers such as skin colour change that can be noticeable, allergic rash or scarring.

发起方

Faculty of Medicine Siriraj Hospital, Mahidol University